Skip to main content
Fig. 1 | Radiation Oncology

Fig. 1

From: High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer

Fig. 1

Sample collection and clinical response. Biopsy samples were obtained at colonoscopy or rigid sigmoidoscopy. Patients then underwent neoadjuvant radio chemotherapy. Patient responses are categorised depending on the degree of tumour regression following neoadjuvant radio chemotherapy as RCPath A (complete tumour regression), RCPath B (partial tumour regression), or RCPath C (no marked tumour regression). Following neoadjuvant radio chemotherapy, resection tissue was obtained from surgery where available

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us